Thermo Fisher Scientific provides the biopharmaceutical industry with a range of laboratory automation solutions with the aim of increasing efficiency and saving R&D costs in the drug discovery process, and to illustrate this, some specific products were mentioned. The complete flexibility of the Thermo Scientific Dimension4™ automation platform was commented upon because of its scalability, configurability, reliability and ability to maintain experiments at high throughput – making it a successful automation solution for any laboratory. The Ultra High Throughput Screening System can analyze close to 180,000 compound tests per day using a fluorescent reader, enabling the ongoing transition to cell-based assays in the drug discovery industry. The reliability of the Polara software platform increases confidence in the data, thereby removing bottlenecks in the data analysis stage.

Commenting on the Award, Christopher McNary, vice president & general manager, laboratory automation solutions, said “We are delighted to receive this award recognizing our range of application-based solutions. Our in-depth expertise in diverse product areas means we can offer an enviable breadth of key technologies, innovative products and advanced software – all driven by customer requirements. Frost & Sullivan has also identified our emphasis on integration which is fundamental to successfully addressing our customers’ needs.”

As well as providing automation capabilities spanning bench-top solutions to comprehensive platforms, Thermo Fisher Scientific also offers a suite of automated solutions addressing specific applications including cell based assays, protein crystallization, ADME/Tox studies and others. McNary continued “Our goal is to provide our customers with the automation solution that meet their drug discovery and development goals, so that they are generating results quickly.”

For more information, please visit www.thermo.com/automate.

Thermo Scientific is part of Thermo Fisher Scientific, the world leader in serving science.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, enabling our customers to make the world healthier, cleaner and safer. With annual sales of more than $9 billion, we employ 30,000 people and serve over 350,000 customers within pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions, government agencies as well as environmental and industrial process control settings. Serving customers through two premier brands, Thermo Scientific and Fisher Scientific, we help solve analytical challenges from routine testing to complex research and discovery. Thermo Scientific offers customers a complete range of high-end analytical instruments as well as laboratory equipment, software, services, consumables and reagents to enable integrated laboratory workflow solutions. Fisher Scientific provides a complete portfolio of laboratory equipment, chemicals, supplies and services used in healthcare, scientific research, safety and education. Together, we offer the most convenient purchasing options to customers and continuously advance our technologies to accelerate the pace of scientific discovery, enhance value for customers and fuel growth for shareholders and employees alike. Visit www.thermofisher.com.